Trials / Completed
CompletedNCT06266598
Effectiveness of Antidiabetic Treatment Applied in Childhood Obesity
The Effect of Anti-diabetic Treatment Applied in Childhood Obesity on Zinc, Zinc α-2 Glycoprotein and Peroxisome Proliferation Activating Receptor-γ Levels
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- HÜMEYRA ACIKAN · Academic / Other
- Sex
- All
- Age
- 9 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
In our study, there are 33 healthy children with normal weight (control group) and 52 obese children who will be treated with metformin. To observe the efficacy of the 3-month treatment before and after metformin treatment, Zn, Zinc α-2 Glycoprotein (ZAG), Peroxisome proliferation activating receptor γ (PPARγ), Leptin (LEP) and Adiponectin (ADIPO) levels were compared, as well as anthropometric measurements and routine biochemistry tests.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | Only obese children with insulin resistance were treated with metformin. |
Timeline
- Start date
- 2019-11-17
- Primary completion
- 2021-08-20
- Completion
- 2021-10-27
- First posted
- 2024-02-20
- Last updated
- 2024-02-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06266598. Inclusion in this directory is not an endorsement.